Icodex Publishing Solutions IPO Subscription, GMP, Details & Reviews

Here is the final call for the Icodex Publishing Solutions IPO launched on 11th August 2025. The issue will be closed for bidding today, on 13th August 2025. The primary aim of the Icodex Publishing Solutions IPO is to raise ₹42.03 crores from the market. Also, the Icodex Publishing Solutions IPO has received an impressive level of subscription, which indicates that shares will be listed at an impeccable premium. Scroll down to check the Icodex Publishing Solutions IPO subscription and details. 

Icodex Publishing Solutions IPO Details 

The price band for the Icodex Publishing Solutions IPO has been prescribed as Rs 98 to ₹102 per share, and 41,20,800 in total shares are to be issued. Let’s segregate the share quota fixed for different categories of investors. 

Icodex Publishing Solutions IPO Subscription Status

As of now, the Icodex Publishing Solutions IPO has been subscribed 1.26 times. Of these, 1.67 times are subscribed by retail investors, 0.86 times by non-institutional investors, and 1.03 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of the Icodex Publishing Solutions IPO listing on 19th August 2025. Icodex Publishing Solutions also has a positive outlook behind the fresh issue of 0.34 crore shares to raise around Rs 42.03 crore.

Icodex Publishing Solutions IPO GMP Today

We know that higher subscriptions encourage grey market premiums for the IPOs. Let’s explore the Icodex Publishing Solutions IPO GMP for 11th August 2025. 

The grey market premium for this IPO is 6.86% or Rs 7 per share. It indicates that the estimated listing price per share is Rs 109. Numerous factors played a pivotal role in this jump in the Icodex Publishing Solutions IPO GMP. These include higher subscriptions received, positive market sentiments, and investors’ positive attitude towards IPO. 

About Icodex Publishing Solutions Ltd.

Icodex Solutions was incorporated in 2018 is operates in the business of software product development that provides products and services to the scholarly publishing industry. They offer technology-driven solutions that include ERP, SAAS to operate business operations smoothly. Icodex Publishing Solutions has experienced promoters and a management team that specialises in the area. Icodex Publishing Solutions Limited has raised an IPO for the utilisation of funds for the expansion of the publication industry and to generate revenue.

Financial Performance

Assess the financial performance of the company for the past three years to get an idea of the Icodex Publishing Solutions IPO listing expectations. 

Technical Indicators

A number of technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Icodex Publishing Solutions IPO.

Icodex Publishing Solutions IPO Listing Expectations

Icodex Publishing Solutions Highlights IPO allotment is still pending as the bid will be closed today. However, as per the current GMP or market sentiments, it is appropriate to expect higher listing gains from the share. A jump of 6.86% in Icodex Publishing Solutions Highlight GMP indicates that the estimated listing price per share will be somewhere around Rs 109.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ best recommendation for the long term. 

Icodex Publishing Solutions IPO Dates

Note: It is to be noted that IPO GMP is volatile based on market sentiment. Hence, one should conduct their research before investing in it.

Recent Articles

Finolex Cables Q1 Results FY26: Q1 PAT Falls 33.33% to ₹162.62 Crore; Revenue Up 13.41% YoY

Abbott India Q1 Results FY26: Q1 PAT Rises 11.54% to ₹365.86 Crore; Revenue Up 11.60% YoY

Jyothy Labs Q1 Results FY26: Q1 PAT Falls 4.95% to ₹96.73 Crore; Revenue Up 1.35% YoY

Zydus Lifesciences Q1 Results FY26: Q1 PAT Rises 3.30% to ₹1,466.80 Crore; Revenue Up 5.90% YoY

Bombay Burmah Trading Q1 Results FY26: Q1 PAT Soars 8.28% to ₹240.70 Crore; Revenue Up 8.73% YoY

Alkem Laboratories Q1 Results FY26: Q1 PAT Rises 21.85% to ₹664.26 Crore; Revenue Up 11.19% YoY

Natco Pharma Q1 Results FY26: Q1 PAT Falls 28.09% to ₹480.70 Crore; Revenue Down 2.47% YoY

Hindalco Q1 Results FY26: Q1 PAT Rises 30.00% to ₹4,004.00 Crore; Revenue Up 13.00% YoY